MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Elanco Animal Health Inc

Cerrado

SectorSanidad

10.79 4.35

Resumen

Variación precio

24h

Actual

Mínimo

10.16

Máximo

10.79

Métricas clave

By Trading Economics

Ingresos

-372M

-8M

Ventas

-10M

1B

P/B

Media del Sector

15.441

63.778

BPA

0.14

Margen de beneficios

-0.784

Empleados

9,000

EBITDA

-779M

8M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+48.12% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-279M

5.2B

Apertura anterior

6.44

Cierre anterior

10.79

Noticias sobre sentimiento de mercado

By Acuity

7%

93%

3 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Elanco Animal Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 jun 2024, 14:34 UTC

Principales Movimientos del Mercado

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

9 jul 2024, 12:30 UTC

Adquisiciones, fusiones, absorciones

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 jul 2024, 12:29 UTC

Adquisiciones, fusiones, absorciones

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 jul 2024, 12:28 UTC

Adquisiciones, fusiones, absorciones

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 jul 2024, 12:28 UTC

Adquisiciones, fusiones, absorciones

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

2 may 2024, 17:43 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 may 2024, 13:06 UTC

Ganancias

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

Comparación entre iguales

Cambio de precio

Elanco Animal Health Inc previsión

Precio Objetivo

By TipRanks

48.12% repunte

Estimación a 12 Meses

Media 15.33 USD  48.12%

Máximo 20 USD

Mínimo 12 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Elanco Animal Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

7

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

10.53 / 10.81Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

3 / 386 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.